W. Michael Brode, MD
Medical Director, Post-COVID-19 Program
Internal Medicine Specialist, Post-COVID-19 Program
Loyola University Chicago, MD
Residency, Internal Medicine, University of Washington
Biography and Education
W. Michael Brode, MD, is a board-certified internal medicine specialist and the Medical Director of UT Health Austin’s Post-COVID-19 Program. He specializes in researching and developing treatments for patients, known as post-COVID-19 “long-haulers,” who are still experiencing symptoms of COVID-19 months after initial infection. Additionally, Dr. Brode is an assistant professor in the Dell Medical School Department of Internal Medicine.
Dr. Bode earned his medical degree from Loyola University Chicago, where he graduated with honors in global health. He completed a residency in internal medicine at the University of Washington and served as the Chief Resident of Global Health through the University of Washington in partnership with the University of Nairobi in Naivasha, Kenya.
Dr. Brode is a clinician educator who emphasizes knowing the patient as a person first, evidence-based diagnosis, and comprehensive care for patients who are most vulnerable. At Dell Medical School, he leads an inter-professional committee that develops treatment guidelines for COVID-19 care. He is also working to improve how the medical system identifies patients’ health-related social needs and connects them to resources through the integration of community health workers into medical treatment. He works with medical students and residents to deliver compassionate, person-centered care for all patients.
- American Board of Internal Medicine, Internal Medicine
Awards & Honors
- Chief Resident of Global Health, University of Washington
- Outstanding Clinician, Dell Medical School Department of Internal Medicine
- Patient Safety Teaching Champion, Dell Medical School